ZAP Surgical Systems, Inc. articles

BACKGROUND AND IMPORTANCE:The Zap-X system (Zap Surgical Systems Inc, SanCarlos, California) is a radically new surgical robot designed for brain and head and neckradiosurgery. It represents the first new dedicated brain stereotactic radiosurgery platformin almost half a century optimizing the goals of safety, speed, and accuracy. The Zap-Xsystem was used in a required Chinese National Medical Products Adm

Abstract

The ZAP-X® is a newly designed, self-contained, and first-of-its-kind self-shielded therapeutic radiationtherapy device dedicated to brain and head and neck stereotactic radiosurgery (SRS). By using an S-bandlinear accelerator (linac) and employing integrated minimal but sufficient shielding, the ZAP-X does nottypically require a radiation bunker. At the same time, the self-shielded features of the ZAP-X are designedfor more consistency of radiation pr

ZAP Surgical Systems, Inc. today announced it has received CE mark clearance to the new EU MDR for its ZAP-X® Gyroscopic Radiosurgery® platform. The CE mark makes it possible for healthcare providers to begin treating patients with the ZAP-X system in the European Union.

For select indications including many primary and metastatic brain tumors, stereotactic radiosurgery (SRS) is proven to be an effective alternative to invasive surgeries. As a non-invasive outpatient procedure

ZAP Surgical Systems, Inc. today announced it has received Shonin approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for its ZAP-X® Gyroscopic Radiosurgery® platform. As part of the approval, ZAP-X is now cleared for clinical use in Japan.

To facilitate a robust market introduction effort, ZAP also announced a partnership with MC Medical Inc. to lead Japanese sales and marketing initiatives. Joining the effort, a partnership with Chiyoda Technol Corpo

ZAP Surgical Systems, Inc. today announced ZAP-X® Gyroscopic Radiosurgery® patient treatments have commenced at MedStar Georgetown Cancer Institute at MedStar Southern Maryland Hospital Center in Clinton, MD.

For many primary and metastatic brain tumors, stereotactic radiosurgery (SRS) has proven to be an effective treatment with outcomes equivalent to invasive surgical procedures. Unlike surgery however, SRS is a non-invasive outpatient procedure with no surgical incision and